David Kestenbaum
David Kestenbaum is a correspondent for NPR, covering science, energy issues and, most recently, the global economy for NPR's multimedia project Planet Money. David has been a science correspondent for NPR since 1999. He came to journalism the usual way — by getting a Ph.D. in physics first.
In his years at NPR, David has covered science's discoveries and its darker side, including the Northeast blackout, the anthrax attacks and the collapse of the New Orleans levees. He has also reported on energy issues, particularly nuclear and climate change.
David has won awards from the American Association for the Advancement of Science, the American Physical Society and the Institute of Electrical and Electronics Engineers.
David worked briefly on the show This American Life, and set up a radio journalism program in Cambodia on a Fulbright fellowship. He also teaches a journalism class at Johns Hopkins University.
David holds a bachelor's of science degree in physics from Yale University and a doctorate in physics from Harvard University.
-
We shop around when we get a plane ticket or buy a couch. But we spend thousands of dollars on health care without comparing prices. What happens when you pay patients to choose the cheaper option?
-
A group of cancer doctors is trying to create a database on cancer drugs. It would give a score for each drug, reflecting how well the drug works. It would also list how much the drug costs.
-
Buying insurance doesn't always feel like it makes economic sense, especially for young healthy people. So why are they still willing to pay? -
With online health-insurance markets set to open this week, it's still unclear whether healthy people will sign up. Yet the success of the program depends on them.
-
Oil sits under a pristine swath of the rainforest. Ecuador promised to leave the forest untouched — if the rest of the world would pay up.
-
It's remarkably rare for leading research hospitals to reject new drugs because of cost.
-
China's foreign-exchange reserves are worth over $3 trillion. That's a problem for China, and for the U.S.
-
The DOJ says it's confident Army scientist Bruce Ivins sent the deadly anthrax letters in 2001. But Ivins' lawyer says dozens, if not hundreds, of scientists and contractors had access to those same anthrax spores. A detailed look at the government's allegations and Ivins' defense.
-
Scientist Bruce E. Ivins was respected by his colleagues at the Army biodefense research center at Fort Detrick in Maryland. His death, and his possible connection to an FBI investigation in the 2001 anthrax killings, hits a tight-knit community.
-
Advocates of NASA's plan to return to the moon are concerned that Democratic presidential candidate Barack Obama has said he will raid NASA's budget to fund education. While the issue of space exploration hasn't gotten much attention this campaign season, it is a topic on which the candidates do differ.
